NASDAQ:DRTS Alpha Tau Medical (DRTS) Stock Price, News & Analysis $13.16 +0.26 (+2.02%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$13.05 -0.11 (-0.82%) As of 10/23/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Alpha Tau Medical Stock (NASDAQ:DRTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alpha Tau Medical alerts:Sign Up Key Stats Today's Range$12.70▼$13.2550-Day Range$12.29▼$15.5052-Week Range$3.43▼$15.79Volume324,635 shsAverage Volume483,080 shsMarket Capitalization$1.19 billionP/E RatioN/ADividend YieldN/APrice Target$15.40Consensus RatingHold Company Overview Alpha Tau Medical Ltd. is an Israel-based medical technology company developing targeted radiation treatments for solid tumors. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver highly localized alpha radiation directly within a tumor while limiting exposure to surrounding healthy tissue. Alpha DaRT uses tiny radioactive sources, including radium-224, that are placed in or near a tumor. The sources generate short-range alpha-emitting atoms that diffuse through the tumor and damage cancer cells. The company has studied the technology in several solid-tumor settings and is advancing it through clinical development for potential use in cancers that may be difficult to treat with conventional approaches. Founded in Israel, Alpha Tau conducts research and clinical-development activities in Israel and other international markets, including the United States and Europe. Alpha DaRT remains an investigational technology, and its availability and use depend on regulatory authorization in each jurisdiction.AI Generated. May Contain Errors. Read More Alpha Tau Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreDRTS MarketRank™: 2.12771666219 of 5 starsAlpha Tau Medical scored higher than 43% of companies evaluated by MarketBeat, and ranked 628th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingHold Consensus RatingAlpha Tau Medical has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 2 sell ratings.Upside PotentialAlpha Tau Medical has a consensus price target of $15.40, representing about 17.0% upside from its current price of $13.16.Amount of Analyst CoverageAlpha Tau Medical has only been the subject of 4 research reports in the past 90 days.Read more about Alpha Tau Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alpha Tau Medical are expected to grow in the coming year, from ($1.05) to ($0.55) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Tau Medical is -12.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Tau Medical is -12.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Tau Medical has a P/B Ratio of 14.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Alpha Tau Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.31% of the float of Alpha Tau Medical has been sold short.Short Interest Ratio / Days to CoverAlpha Tau Medical has a short interest ratio ("days to cover") of 6.63.Change versus previous monthShort interest in Alpha Tau Medical has recently decreased by 1.02%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Tau Medical does not currently pay a dividend.Dividend GrowthAlpha Tau Medical does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.16 News SentimentAlpha Tau Medical has a news sentiment score of -0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Alpha Tau Medical this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for DRTS on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows2 people have added Alpha Tau Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Alpha Tau Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $291,285.00 in company stock.Percentage Held by Insiders39.50% of the stock of Alpha Tau Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions2.65% of the stock of Alpha Tau Medical is held by institutions.Read more about Alpha Tau Medical's insider trading history. Receive DRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRTS Stock News HeadlinesAlpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in KoreaOctober 22 at 9:00 AM | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC WainwrightOctober 22 at 2:18 AM | americanbankingnews.comElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.October 25 at 1:00 AM | Paradigm Press (Ad)Alpha Tau Medical Gets FDA Approval to Expand Brain Cancer TrialOctober 19, 2026 | marketscreener.comMAlpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual MeetingOctober 19, 2026 | globenewswire.comAlpha Tau Medical (DRTS) dominates Reddit with 267 comments on Oct. 5October 5, 2026 | 247wallst.comAlpha Tau to Participate in October Investor ConferencesOctober 5, 2026 | globenewswire.comAlpha Tau Medical consensus price target raised 23.61% to $18.16September 15, 2026 | msn.comSee More Headlines DRTS Stock Analysis - Frequently Asked Questions How have DRTS shares performed this year? Alpha Tau Medical's stock was trading at $4.95 at the start of the year. Since then, DRTS shares have increased by 165.9% and is now trading at $13.16. How were Alpha Tau Medical's earnings last quarter? Alpha Tau Medical Ltd. (NASDAQ:DRTS) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.14) by $0.36. How do I buy shares of Alpha Tau Medical? Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alpha Tau Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Tau Medical investors own include NVIDIA (NVDA), Vaalco Energy (EGY), Enbridge (ENB), Enterprise Products Partners (EPD), Freeport-McMoRan (FCX), Trilogy Metals (TMQ) and Uranium Energy (UEC). Company Calendar Last Earnings8/10/2026Today10/25/2026Next Earnings (Estimated)11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (14m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 DRTS's financial health is in the Green zone, according to TradeSmith. DRTS has been in this zone for over 14 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:DRTS CIK1871321 Webwww.alphatau.com Phone972-3577-4115FaxN/AEmployees121Year Founded2016Price Target and Rating Average Price Target for Alpha Tau Medical$15.40 High Price Target$30.00 Low Price Target$8.00 Potential Upside/Downside+17.0%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($1.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$42.63 million Net MarginsN/A Pretax MarginN/A Return on Equity-138.12% Return on Assets-81.68% Debt Debt-to-Equity Ratio0.15 Current Ratio11.09 Quick Ratio7.79 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.88 per share Price / Book14.95Miscellaneous Outstanding Shares90,326,000Free Float54,647,000Market Cap$1.19 billion OptionableOptionable Beta1.22 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:DRTS) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
